# üìÖ Final 18-Month Strategic Roadmap: ai.biodockify.com

**Version**: 3.0 (Research & Validation Focused)  
**Goal**: Establish the #1 Free AI Drug Discovery Platform & Secure IP  
**Philosophy**: Build -> Validate -> Patent -> Scale

---

## üß≠ Executive Timeline

| Quarter | Phase Name | Key Objective | Status |
|:---:|:---:|:---|:---:|
| **Q1** | **Genesis (Months 1-3)** | **Build & Launch**: Complete Implementation Phases 0-4. Focus on **Alzheimer's & Cancer**. | üöÄ Active |
| **Q2-Q3** | **Validation (Months 4-9)** | **Science & IP**: Rigorous testing, Case Studies, Publication, **Patent Filing**. | üìÖ Planned |
| **Q4** | **Scaling (Months 10-12)** | **Expansion**: Scale to 20+ diseases. Active Learning. | üîÆ Scope |
| **Q5-Q6** | **Global (Months 13-18)** | **Deep Tech**: Advanced ADMET, Sustainability, Global Partnerships. | üîÆ Scope |

---

## üçÇ Quarter 1: The Build (Genesis)
*Focus: Completing the 4-Phase Implementation Plan & Releasing MVP.*

> **Key Deliverable**: Fully functional platform with **Alzheimer's** (BACE1) and **Cancer** (TP53) models.

### Month 1: Foundation (Phases 0-1)
- **Infra**: Backend on HuggingFace, Frontend on Vercel.
- **Data**: Ingest ChEMBL data for Alzheimer's.
- **Status**: ‚úÖ Completed.

### Month 2: Intelligence (Phases 2-3)
- **Models**: Train ChemBERTa for Alzheimer's.
- **Toxicity**: Implement Rule-based Tox Engine.
- **Status**: üöß In Progress.

### Month 3: Automation (Phase 4) & Launch
- **Auto-QSAR**: Allow users to train custom models (RandomForest).
- **Integration**: Full End-to-End verified workflow.
- **Public Beta**: Release to initial user group.

---

## ‚ùÑÔ∏è Quarter 2 & 3: The Proof (Validation & IP)
*Focus: Proving the science works before scaling. "Testing, Validation, Publication, Patent".*
### Month 3: Next-Gen Intelligence (Phase 5 - SOTA Upgrade)
- [ ] **MolFormer-XL Implementation**: Deploy `ibm/MoLFormer-XL-both-10pct` using 4-bit Quantization (QLoRA).
- [ ] **Massive Screening**: Validate efficient linear attention on long chains.
- [ ] **Goal**: Achieve SOTA performance with 1.1B parameters on T4 GPU.

### Month 4-5: Rigorous Testing
- [ ] **Retrospective Validation**: Reproduce known drug discoveries using MolFormer.
- [ ] **Benchmarking**: Compare BioDockify vs. standard tools (Schr√∂dinger, AutoDock).
- [ ] **Case Study**: "Rediscovering Donepezil" (Whitepaper).

### Month 6-7: Publication & IP
- [ ] **Draft Paper**: "Accessible AI for Polypharmacology" (Target Bioinformatics journals).
- [ ] **Patent Filing**: File provisional patent for the *Auto-QSAR Workflow* or specific archival architecture.
- [ ] **Peer Review**: Submit findings to preprint servers (BioRxiv).

### Month 8-9: Refinement
- [ ] **Feedback Loop**: Incorporate peer reviewer feedback into the model.
- [ ] **Hardening**: Fix edge cases discovered during validation stringency.

---

## üå∑ Quarter 4: The Scale
*Focus: Expanding from 2 diseases to 20+.*

### Month 10: The 20-Disease Sprint
- [ ] **Neglected Tropical Diseases**: Add Malaria, TB, Dengue models.
- [ ] **Rare Diseases**: Partner with research groups.

### Month 11: Active Learning
- [ ] **Feedback System**: "Report Incorrect Prediction" button.
- [ ] **Auto-Retrain**: Pipelines that get smarter with user data.

### Month 12: Community
- [ ] **Model Marketplace**: Allow users to share their validated models.

---

## ‚òÄÔ∏è Quarter 5 & 6: The Future (Sustainability)
*Focus: Long-term growth and advanced technology.*

### Month 13-15: Deep Tech
- [ ] **3D Visualization**: Interaction analysis in browser.
- [ ] **Advanced ADMET**: Deep learning for toxicity.

### Month 16-18: Sustainability
- [ ] **Grants**: Apply for major research funding.
- [ ] **Partnerships**: University & Pharma tie-ins.

---

## üí∞ Resource Plan (18 Months)

### Infrastructure Cost
- **Q1-Q3**: **‚Çπ0** (Free Tier Validation).
- **Q4+**: **‚Çπ1000/mo** (Scaling might require small GPU resources).

### Team Focus
- **Q1**: Coding & Engineering.
- **Q2-Q3**: Research, Writing, Analysis.
- **Q4**: Data Engineering.

---

## üöÄ Immediate Next Step
**Finish Phase 4 Automation (Auto-QSAR)** to complete Q1 objectives.
